# Multiple Ascending Oral Dose Phase I Study With Px-102

> **NCT01998672** · PHASE1 · COMPLETED · sponsor: **Phenex Pharmaceuticals AG** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Px-102
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01998672
- **Lead sponsor:** Phenex Pharmaceuticals AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01998672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01998672, "Multiple Ascending Oral Dose Phase I Study With Px-102". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01998672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*